Stone and Laser Therapies Post-Market Study (SALT)
Start Date
6/30/2025
Completion Date
2/1/2029
Summary
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
Detailed Description
The SALT study is a multi-center, open label, non-randomized, prospective observational study to document on-going post-market safety and device performance data of BSC commercially available study devices that are used in diagnostic and/or therapeutic urinary tract procedures or surgical treatment for BPH. Enrolled subjects undergoing diagnostic or therapeutic procedures using study devices will be followed for 1 year after the index procedure is complete.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
Ureteroscope system
Laser system
Conditions
Locations
Mayo Clinic Phoenix
Phoenix, Arizona 85054
United States
University of Miami Hospital
Miami, Florida 33442
United States
University of South Florida
Tampa, Florida 33606
United States
Indiana University Medical Center
Indianapolis, Indiana 46202
United States
Duke University Medical Center
Durham, North Carolina 27710
United States